
According to latest medical reports, stress is found to be among the largest killers of human kind and numerous western medications have found to have worsen the medical condition with a number of side effects.
Consider this scenario: jam packed roads, a looming deadline or getting laid off.
In today’s modern world, stress and anxiety is seen in terms of the situation one finds oneselves in.
Headaches, anxiety, insomnia, depression, fatigue and feelings of anger, fear, helplessness or hopelessness, and other symptoms that affect a person’s physical and mental well-being are often linked to stress.
Often angry, frustrated and irritated,
Frequent headaches, stomach aches and back aches
For More Information: www.ayurcentre.sg


A completely natural Ayurvedic medicine for insomnia, depression, stress and anxiety, Manasamitran Gulika, is one of the safest medications that one can have.
People suffering from sleeplessness, anxiety issues, irritability and frustration can consume this Ayurvedic medicine for anxiety and relax the mind for a sound sleep at night.



A depressed person may gain or lose weight, eat more or less than usual, have difficulty concentrating, and have trouble sleeping or sleep more than usual.
A particularly painful symptom of this illness is an unshakable feeling of worthlessness and guilt.
This therapy can help patient in changing the thinking patterns and improve coping skills so an individual better equipped to deal with life's stresses and conflicts.
As per DelveInsight estimation, in upcoming years, new techniques, such as proteomics and metabolomics, which allow researchers to approach the studying of MDD with new directions and make new discoveries will be addressed.Therapies based on nociceptin receptor antagonist, Botox, selective orexin 2 receptor antagonist are currently under development.
If these therapies are ultimately successfully commercialized they have the potential to transform the current standard of care for Major Depressive Disorder (MDD) patients.The increase in Market Size is a direct consequence of increasing prevalent population of Major Depressive Disorder (MDD) patients in the 7MM, along with expected entry of premium price asset such nociception receptor antagonist , Botox, selective orexin 2 receptor antagonist will have impact on market size.Also, Read- Major Depressive Disorder Market ReportDepression is one of the most common and serious mental disorders.
According to the Global Burden of Disease Study of the WHO, it is one of the main causes of disease-related disability worldwide and accounts for a large part of the global disease burden.

